🧬 A phase II study testing neoadjuvant camrelizumab + apatinib w/o chemotherapy in head & neck cancer observed pathologic response in 29.3% of pts. Also, PD-L1, CTC clearance emerged as a biomarker of interest.
#HNSCC #Immunotherapy #ClinicalTrials
pubmed.ncbi.nlm.nih.gov/4271…
21
New results in @SciSignal reveal that the T cell adaptor protein PAG supports the function of #TCell immune synapses by connecting with actin, suggesting that it could offer a target to improve #immunotherapy in patients that show poor responses. scim.ag/4rsHYYJ
4
8
41
27,879
Dr Charlotte Pawlyn, Group Leader of Myeloma Biology and Therapeutics at ICR London, joined the 1st session to discuss “The management of older patients with Myeloma in the immunotherapy era”
#MyelomaResearch #Immunotherapy #IMMS26
24
It was lovely to speak with Alessandro Di Federico (@DiFedericoMD) at #WCLC26 to discuss how Class 3 #BRAF alterations affect #immunotherapy outcomes in #NSCLC 🎯🫁
Watch: ow.ly/z77G50ZPM7r
#Oncology #LungCancer #LCSM #ImmunoOnc @IASLC @MSKCancerCenter
1
4
665
Should've spoken abt gross apathy n blanket fraudulent activities ins cos @StarHealthIns , @heydigit etc engage In by keeping a ceiling on d only line of treatment avlbl 2 a #Cancer patient, I.e expensive #Immunotherapy whr 1 vial cost 2l itself ! INS COs DESTROYS FAMS N LIVES 2!
1
62
🧪 In resectable NSCLC, presurgical ctDNA clearance was seen as a strong marker associated with outcomes in the CheckMate 77 trial.
#LungCancer #Immunotherapy #Biomarkers #MedComms
nature.com/articles/s41586-0…
29
Emerging cellular immunotherapies are expanding beyond CAR-T, bringing new opportunities—and new safety, ethical & regulatory challenges. Explore how Sponsors, Investigators & IRBs can support responsible innovation in next-generation.
pharmafocusamerica.com/manuf…
#Immunotherapy
6
Put this out there again, 3 of 12 #Chemo sessions in, #Radiotherapy to start with next round 30 sessions in 15 days, then possibly #Immunotherapy
Any support is greatly appreciated, but, not expected.
#Cancer
#Battle
#WeWillWin
1
3
7
445
David Russler-Germain, MD/PhD retweeted
Great victory for #immunotherapy ! CD19 engager works better than #chemotherapy for #leukemia
New England Journal of Medicine paper
nejm.org/doi/10.1056/NEJMoa2…
1
1
33
1,885
$CTSO CytoSorbents Expects to File a New De Novo Application for DrugSorb-ATR in early 2027 #medtech #immunotherapy buff.ly/r68FsDt
221
🎙️ New JTO Insights episode!
@DrAlexAdjei and @TommyJohn00 welcome Dr. Karen L. Reckamp for a 20-year look at the evolution of #immunotherapy in lung cancer and the advances that have reshaped treatment.
🎧 Listen now: bit.ly/4hEPaxm
#JTOInsights #LungCancer #ThoracicOncology #JTO20
1
4
9
544
🧪@Columbia engineered E. coli act as “drug factories” inside tumors - a fascinating #syntheticbiology approach. By converting 5-FC to 5-FU locally & delivering #immunotherapy payloads, the platform combines targeted #chemotherapy with immune activation. linkedin.com/posts/drmelvins…
5
8
578
Conformation-specific anti-pathological tau #antibody raised against AD brain-derived seed-competent tau reduces tau pathology in transgenic mice
Kiran Yanamandra, Nandini Romanul, Hiral Patel...Xavier Langlois @abbvie #AlzheimersDisease #immunotherapy
link.springer.com/article/10…
29
Never4getJ13🇺🇸 retweeted
Peer reviewed paper showing Ivermectin as #cancer #immunotherapy
Read it before they take it down !
@SabinehazanMD $nwbo $tsoi $cldi
#covid19 #quadramune
nature.com/articles/s41523-0…
179
752
2,029
1,203,136
Beyond chemotherapy, targeted therapies like immunotherapy show immense promise, especially for certain cancers. Now, researchers explore using apheresis to target galectin-3, aiming to boost immunotherapy's effectiveness. #CancerResearch #Immunotherapy #MedicalInnovation
86